Search

Author/Creator Hitz, F.

1. Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. (October 2016)

Authors:
Neumair, P.; Joos, L.; Warschkow, R.; Dutly, A.; Ess, S.; Hitz, F.; Früh, M.; Brutsche, M.; Baty, F.; Krähenbühl, S.; Cerny, T.; Joerger, M.
Journal:
Lung cancer
Issue:
Volume 100(2016)
Page Start:
38
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. PROGNOSTIC IMPLICATIONS OF THE MICROENVIRONMENT IN FOLLICULAR LYMPHOMA UNDER RITUXIMAB AND RITUXIMAB+LENALIDOMIDE THERAPY. A TRANSLATIONAL STUDY OF THE SAKK35/10 TRIAL. (12th June 2019)

Authors:
Menter, T.; Tzankov, A.; Zucca, E.; Kimby, E.; Vanazzi, A.; Østenstad, B.; Mey, U.J.; Rauch, D.; Wahlin, B.; Hitz, F.; Hernberg, M.; Johansson, A.; de Nully Brown, P.; Hagberg, H.; Hawle, H.; Hayoz, S.; Dirnhofer, S.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
149
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION WITH VENETOCLAX IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS. (12th June 2019)

Authors:
Stathis, A.; Mey, U.; Schär, S.; Hitz, F.; Pott, C.; Mach, N.; Krasniqi, F.; Novak, U.; Schmidt, C.; Hohloch, K.; Kienle, D.; Hess, D.; Moccia, A.; Unterhalt, M.; Eckhardt, K.; Hayoz, S.; Rossi, D.; Dirnhofer, S.; Ceriani, L.; Bertoni, F.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
118
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH HODGKIN'S LYMPHOMA OLDER THAN 60 YEARS TREATED IN SWITZERLAND OVER THE LAST 17 YEARS. (12th June 2019)

Authors:
Aeppli, S.; Moccia, A.; Bargetzi, M.; Brülisauer, D.; Caspar, C.; Ebnöther, M.; Fehr, M.; Fischer, N.; Ghilardi, G.; Krasniqi, F.; Lang, N.; Mey, U.; Mingrone, W.; Novak, U.; Richter, P.; Rütti, M.; Schmidt, A.; Stenner, F.; Voegeli, M.; Zander, T.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
289
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland. Issue 2 (23rd December 2020)

Authors:
Moccia, A. A.; Aeppli, S.; Güsewell, S.; Bargetzi, M.; Caspar, C.; Brülisauer, D.; Ebnöther, M.; Fehr, M.; Fischer, N.; Ghilardi, G.; Krasniqi, F.; Lang, N.; Mey, U.; Mingrone, W.; Novak, U.; Pfleger, C.; Richter, P.; Rütti, M.; Schmidt, A.; Stenner, F.
Journal:
Hematological oncology
Issue:
Volume 39:Issue 2(2021)
Page Start:
196
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. S222: MATURE T AND NK CELL LYMPHOMAS CLASSIFIED ACCORDING TO 2016 WHO CLASSIFICATION. A REPORT OF THE INTERNATIONAL PROSPECTIVE T-CELL PROJECT 2.0. (23rd June 2022)

Authors:
Federico, M.; Stepanishyna, Y.; Skrypets, T.; Chiattone, C. S.; Prince, M. H.; Pavlovsky, A.; Lymboussakis, A.; Manni, M.; Civallero, M.; de Souza, C. A.; Hawkes, E. A.; Fiad, L.; Nair, R.; Kriachok, I.; Hitz, F.; Kostina, O.; Tomuleasa, C.; Guarini, A.; Luminari, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
123
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. (October 2016)

Authors:
Neumair, P.; Joos, L.; Warschkow, R.; Dutly, A.; Ess, S.; Hitz, F.; Früh, M.; Brutsche, M.; Baty, F.; Krähenbühl, S.; Cerny, T.; Joerger, M.
Journal:
Lung cancer
Issue:
Volume 100(2016)
Page Start:
38
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. IMPROVED SURVIVAL OUTCOMES FOR PATIENTS WITH EXTRA‐NODAL NK/T LYMPHOMA: DATA FROM 140 PATIENTS PROSPECTIVELY REGISTERED IN THE INTERNATIONAL T‐CELL PROJECT. (June 2017)

Authors:
Fox, C.P.; Bellei, M.; Manni, M.; Kim, S.J.; Ko, Y.H.; Shustov, A.R.; Cabrera, M.E.; Chiattone, C.S.; Horwitz, S.M.; Spina, M.; Advani, R.H.; Angrilli, F.; De Souza, C.A.; Dlouhy, I.; Fernandez‐Alvarez, R.; Gabús, R.; Hitz, F.; Laszlo, D.; Montoto, S.; Nagler, A.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
78
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗